To main content To main navigation

More-EUROPA

We work towards a more efficient use of real-world data in the development, registration and assessment of medicinal products in Europe
We work towards a more efficient use of real-world data in the development, registration and assessment of medicinal products in Europe
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized.
The aim of our project is to develop, implement and establish evidentiary standards and methods to address the data and evidentiary needs of regulatory authorities and health technology assessment (HTA) bodies towards a more efficient use of RWD for the development, registration and assessment of medicinal products in Europe.


 

Contact

E-mail: [email protected]

Lysbeth Bakker, project manager
Peter Mol, project coordinator
Sieta de Vries, project co-lead